ebook Munafa Stock Market Course + Intraday & FNO calls  

       

BMRN announcements Biomarin Pharmaceutical Inc. announcements and dividends declared NASDAQ

Biomarin Pharmaceutical Inc. Complete list of announcements declared & dividend announcements by Biomarin Pharmaceutical Inc. BMRN

Biomarin Pharmaceutical Inc. BMRN listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Biomarin Pharmaceutical Inc. BMRN

Is the Options Market Predicting a Spike in BioMarin Pharmaceutical Stock?
Investors need to pay close attention to BioMarin Pharmaceutical stock based on the movements in the options market lately.
Announcement as on 28 May 2025

RBC Capital Reiterates Biomarin Pharmaceutical Inc. - Registered Shares (BMRN) Sector Perform Recommendation
Fintel reports that on September 13, 2023, RBC Capital reiterated coverage of Biomarin Pharmaceutical Inc. - Registered Shares (NASDAQ:BMRN) with a Sector Perform recommendation.
Announcement as on 14 September 2023

Guggenheim Reiterates Biomarin Pharmaceutical Inc. - Registered Shares (BMRN) Buy Recommendation
Fintel reports that on September 13, 2023, Guggenheim reiterated coverage of Biomarin Pharmaceutical Inc. - Registered Shares (NASDAQ:BMRN) with a Buy recommendation.
Announcement as on 14 September 2023

Why BioMarin Pharmaceuticals Fell 6.9% on Thursday
BioMarin Pharmaceuticals (NASDAQ: BMRN), a biopharmaceutical company that specializes in finding therapies for rare genetic diseases, saw its shares drop 6.9% on Thursday after falling as much as 9.8% earlier in the day. The stock closed on Wednesday at
Announcement as on 27 October 2022

BioMarin Pharmaceutical (BMRN) Surpasses Q3 Earnings Estimates
BioMarin Pharmaceutical (BMRN) came out with quarterly earnings of [CO].45 per share, beating the Zacks Consensus Estimate of [CO].37 per share. This compares to earnings of [CO].18 per share a year ago. These figures are adjusted for non-recurring items.
Announcement as on 26 October 2022

Announcements by Biomarin Pharmaceutical Inc. first page | Next page |

BMRN Biomarin Pharmaceutical Inc. current price & indicator signals

Moving Averages for Biomarin Pharmaceutical Inc.

  • 5Day Average: 54.09
  • 12Day Average: 54.45
  • 20Day Average: 54.27
  • 50Day Average: 53.85
  • 100Day Average: 55.53
  • 150Day Average: 56.22
  • 200Day Average: 58.68

BMRN Indicators & signals

Indicator MACD (12,26,9)

54.3, 54.16, 0.25
Indicator MACD is in positive zone

Indicator ADX (14)

21.88, 16.56, 25.83
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 51
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of BMRN Biomarin Pharmaceutical Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Fri Dec 2025 53.40 52.88 to 53.83 -0.78% 0.58 times
04 Thu Dec 2025 53.82 53.64 to 54.66 -0.9% 0.51 times
03 Wed Dec 2025 54.31 53.03 to 54.40 0.78% 0.6 times
02 Tue Dec 2025 53.89 53.88 to 55.34 -2.07% 0.57 times
01 Mon Dec 2025 55.03 54.95 to 56.09 -1.61% 0.63 times
28 Fri Nov 2025 55.93 55.03 to 56.05 0.74% 0.32 times
26 Wed Nov 2025 55.52 54.51 to 56.39 -1.42% 0.96 times
25 Tue Nov 2025 56.32 55.35 to 56.45 1.48% 0.33 times
24 Mon Nov 2025 55.50 53.93 to 56.13 1.48% 4.69 times
21 Fri Nov 2025 54.69 52.51 to 54.76 4.21% 0.81 times
20 Thu Nov 2025 52.48 52.36 to 53.73 -0.15% 0.57 times
19 Wed Nov 2025 52.56 51.99 to 53.88 -2.95% 0.55 times

Videos related to: BMRN announcements Biomarin Pharmaceutical Inc. announcements and dividends declared NASDAQ

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

BMRN announcements Biomarin Pharmaceutical Inc. announcements and dividends declared NASDAQ

 

Back to top